Cachet Pharmaceutical Co., Ltd.
Symbol: 002462.SZ
SHZ
12.28
CNYDzisiejsza cena rynkowa
14.3690
Wskaźnik P/E
0.7993
Wskaźnik PEG
3.58B
Kapitalizacja MRK
- 0.02%
Rentowność DIV
Cachet Pharmaceutical Co., Ltd. (002462-SZ) Sprawozdania finansowe
Bilans
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 10532.55 | 2885.6 | 2183.7 | 2338.4 | |||||||||||||||||
balance-sheet.row.short-term-investments | 0.59 | 0.1 | 0.2 | 0.2 | |||||||||||||||||
balance-sheet.row.net-receivables | 38852.37 | 9187.4 | 9948 | 8640.8 | |||||||||||||||||
balance-sheet.row.inventory | 10431.64 | 2561.7 | 2692.3 | 2185.4 | |||||||||||||||||
balance-sheet.row.other-current-assets | 630.57 | 156.7 | 171.6 | 120.8 | |||||||||||||||||
balance-sheet.row.total-current-assets | 60447.13 | 15630.5 | 14995.6 | 13285.3 | |||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 2752.52 | 679.7 | 735.9 | 850.3 | |||||||||||||||||
balance-sheet.row.goodwill | 1983.55 | 475.9 | 515.9 | 562.4 | |||||||||||||||||
balance-sheet.row.intangible-assets | 142.71 | 35.6 | 35.8 | 36.6 | |||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 2126.27 | 511.4 | 551.7 | 599 | |||||||||||||||||
balance-sheet.row.long-term-investments | 7.78 | 1.7 | 2.3 | 2.3 | |||||||||||||||||
balance-sheet.row.tax-assets | 374.33 | 93 | 68.1 | 52.6 | |||||||||||||||||
balance-sheet.row.other-non-current-assets | 789.85 | 204.4 | 203 | 148.2 | |||||||||||||||||
balance-sheet.row.total-non-current-assets | 6050.75 | 1490.3 | 1561 | 1652.3 | |||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-assets | 66497.88 | 17120.9 | 16556.6 | 14937.5 | |||||||||||||||||
balance-sheet.row.account-payables | 23067.09 | 5858.1 | 5319.5 | 4442.4 | |||||||||||||||||
balance-sheet.row.short-term-debt | 14121.28 | 3842.7 | 4068 | 3774.5 | |||||||||||||||||
balance-sheet.row.tax-payables | 394.27 | 115.5 | 96.8 | 99.8 | |||||||||||||||||
balance-sheet.row.long-term-debt-total | 781.08 | 175.9 | 208.8 | 229.2 | |||||||||||||||||
Deferred Revenue Non Current | -4.3 | -4.3 | 0 | 0 | |||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 30.66 | - | - | - | |||||||||||||||||
balance-sheet.row.other-current-liab | 130.84 | 53 | 732.8 | 34 | |||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 811.74 | 180.2 | 220 | 259.2 | |||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.capital-lease-obligations | 781.08 | 175.9 | 208.8 | 229.2 | |||||||||||||||||
balance-sheet.row.total-liab | 42070.44 | 11029.3 | 10635 | 9281 | |||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.common-stock | 1166.83 | 291.7 | 291.7 | 291.7 | |||||||||||||||||
balance-sheet.row.retained-earnings | 9684.4 | 2430.6 | 2268.1 | 2079.1 | |||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 3516.49 | 0 | 240 | 237.6 | |||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 2556.4 | 1518.2 | 1278.2 | 1278.2 | |||||||||||||||||
balance-sheet.row.total-stockholders-equity | 16924.12 | 4240.5 | 4078 | 3886.5 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 66497.88 | 17120.9 | 16556.6 | 14937.5 | |||||||||||||||||
balance-sheet.row.minority-interest | 7503.32 | 1851 | 1843.6 | 1770 | |||||||||||||||||
balance-sheet.row.total-equity | 24427.44 | 6091.5 | 5921.6 | 5656.6 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 66497.88 | - | - | - | |||||||||||||||||
Total Investments | 8.37 | 1.7 | 2.4 | 2.5 | |||||||||||||||||
balance-sheet.row.total-debt | 14902.36 | 4018.7 | 4276.8 | 4003.8 | |||||||||||||||||
balance-sheet.row.net-debt | 4370.4 | 1133.2 | 2093.2 | 1665.6 |
Rachunek przepływów pieniężnych
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 257.86 | 468.3 | 601.9 | 590.9 | ||||||||||||||||
cash-flows.row.depreciation-and-amortization | 168.35 | 226.7 | 201.1 | 175.9 | ||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | -34.3 | -3.5 | 0.3 | ||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 34.3 | 3.5 | -0.3 | ||||||||||||||||
cash-flows.row.change-in-working-capital | -528.8 | -1216.3 | -133.8 | -47.7 | ||||||||||||||||
cash-flows.row.account-receivables | -601.58 | -2437.7 | -655.1 | -699 | ||||||||||||||||
cash-flows.row.inventory | 72.78 | -510.7 | -179.8 | 183.5 | ||||||||||||||||
cash-flows.row.account-payables | 0 | 1766.3 | 704.7 | 467.5 | ||||||||||||||||
cash-flows.row.other-working-capital | 0 | -34.3 | -3.5 | 0.3 | ||||||||||||||||
cash-flows.row.other-non-cash-items | 1271.58 | 357.8 | 243.9 | 395.7 | ||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 1168.99 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -197.7 | -188.5 | -247 | -258 | ||||||||||||||||
cash-flows.row.acquisitions-net | 50.76 | -1.6 | 59.2 | 1.4 | ||||||||||||||||
cash-flows.row.purchases-of-investments | 3.92 | 0 | -16.2 | -42 | ||||||||||||||||
cash-flows.row.sales-maturities-of-investments | -25.33 | 10.9 | 2.3 | 1 | ||||||||||||||||
cash-flows.row.other-investing-activites | 31.44 | 3.8 | -55.5 | 4.1 | ||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -168.68 | -175.4 | -257.1 | -293.5 | ||||||||||||||||
cash-flows.row.debt-repayment | -3431.74 | -4619.6 | -3975.2 | -4948.4 | ||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.dividends-paid | -207.44 | -282.3 | -242.7 | -289.1 | ||||||||||||||||
cash-flows.row.other-financing-activites | 1938.41 | 4739.1 | 3884.8 | 4864 | ||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -753.17 | -162.8 | -333.1 | -373.5 | ||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | -0.7 | -0.4 | ||||||||||||||||
cash-flows.row.net-change-in-cash | 247.14 | -501.7 | 322.2 | 447.4 | ||||||||||||||||
cash-flows.row.cash-at-end-of-period | 8914.64 | 1699.3 | 2201 | 1878.8 | ||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 8667.5 | 2201 | 1878.8 | 1431.4 | ||||||||||||||||
cash-flows.row.operating-cash-flow | 1168.99 | -163.4 | 913.1 | 1114.9 | ||||||||||||||||
cash-flows.row.capital-expenditure | -197.7 | -188.5 | -247 | -258 | ||||||||||||||||
cash-flows.row.free-cash-flow | 971.3 | -352 | 666.2 | 856.9 |
Wiersz rachunku zysków i strat
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 30683.14 | 29996.2 | 26219.8 | 25625.6 | |||||||||||||||||
income-statement-row.row.cost-of-revenue | 28755.67 | 28018.5 | 24112.2 | 23484.9 | |||||||||||||||||
income-statement-row.row.gross-profit | 1927.46 | 1977.7 | 2107.6 | 2140.8 | |||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-general-administrative | 61.72 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 678.23 | - | - | - | |||||||||||||||||
income-statement-row.row.other-expenses | -0.53 | -12 | 263.7 | 234.2 | |||||||||||||||||
income-statement-row.row.operating-expenses | 1023.97 | 1072.1 | 1162 | 1103.7 | |||||||||||||||||
income-statement-row.row.cost-and-expenses | 29779.65 | 29090.6 | 25274.3 | 24588.6 | |||||||||||||||||
income-statement-row.row.interest-income | 189.45 | 31.1 | -22.4 | 17.1 | |||||||||||||||||
income-statement-row.row.interest-expense | 73.91 | 155.4 | 175.3 | 164.2 | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 678.23 | - | - | - | |||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -217.24 | -350.4 | -292 | -6.8 | |||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.other-operating-expenses | -0.53 | -12 | 263.7 | 234.2 | |||||||||||||||||
income-statement-row.row.total-operating-expenses | -217.24 | -350.4 | -292 | -6.8 | |||||||||||||||||
income-statement-row.row.interest-expense | 73.91 | 155.4 | 175.3 | 164.2 | |||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 281.99 | 202.1 | 226.7 | 408.3 | |||||||||||||||||
income-statement-row.row.ebitda-caps | 904.8 | - | - | - | |||||||||||||||||
income-statement-row.row.operating-income | 573.55 | 556.4 | 936.9 | 830.8 | |||||||||||||||||
income-statement-row.row.income-before-tax | 583.96 | 555.3 | 644.9 | 824 | |||||||||||||||||
income-statement-row.row.income-tax-expense | 187.67 | 178.7 | 176.6 | 222.1 | |||||||||||||||||
income-statement-row.row.net-income | 257.86 | 250.1 | 468.3 | 601.9 |
Często zadawane pytania
Ile wynosi Cachet Pharmaceutical Co., Ltd. (002462.SZ) aktywów ogółem?
Cachet Pharmaceutical Co., Ltd. (002462.SZ) całkowite aktywa to 17120851592.000.
Jaki jest roczny przychód przedsiębiorstwa?
Roczny przychód to 15651563096.000.
Jaka jest marża zysku firmy?
Marża zysku firmy to 0.063.
Czym są wolne przepływy pieniężne firmy?
Wolne przepływy pieniężne to 3.329.
Jaka jest marża zysku netto przedsiębiorstwa?
Marża zysku netto to 0.008.
Jaki jest całkowity przychód firmy?
Całkowity przychód to 0.019.
Co to jest Cachet Pharmaceutical Co., Ltd. (002462.SZ) zysk netto (dochód netto)?
Zysk netto (dochód netto) wynosi 250060041.000.
Jakie jest całkowite zadłużenie firmy?
Całkowite zadłużenie to 4018688843.000.
Ile wynoszą koszty operacyjne?
Wydatki operacyjne to 1072054997.000.
Jaka jest wartość gotówki firmy?
Środki pieniężne przedsiębiorstwa to 2853572169.000.